Basics Avidity Biosciences, Inc. IPO Date: June 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $10.21B Activated in VL: False Average Daily Range Avg Daily Range: $0.76 | 3.27% Avg Daily Range (30 D): $1.16 | 2.54% Avg Daily Range (90 D): $1.09 | 2.65% Institutional Daily Volume Avg Daily Volume: .86M Avg Daily Volume (30 D): 4.5M Avg Daily Volume (90 D): 3.25M Trade Size Avg Trade Size (Sh.): 80 Avg Trade Size (Sh.) (30 D): 139 Avg Trade Size (Sh.) (90 D): 101 Institutional Trades Total Inst.Trades: 3,446 Avg Inst. Trade: $3.39M Avg Inst. Trade (30 D): $4.92M Avg Inst. Trade (90 D): $4.65M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $4.56M Avg Closing Trade (30 D): $20.67M Avg Closing Trade (90 D): $14.74M Avg Closing Volume: 163.69K     News Nov 22, 2025 @ 10:34 AM Halper Sadeh LLC Encourages WTRG, RNA, TCBX Shareh... Source: Halper Sadeh Llc Nov 20, 2025 @ 5:43 PM Novartis Projects Faster Growth Through 2030 After... Source: Vandana Singh Oct 28, 2025 @ 10:58 AM Novartis Maintains Outlook Even As Generics Bite I... Source: Vandana Singh Oct 27, 2025 @ 10:17 PM Why Dyne Therapeutics Stock Crushed the Market on ... Source: Eric Volkman Oct 27, 2025 @ 10:11 AM Avidity Shareholders Win Big As Novartis Moves Fas... Source: Lekha Gupta Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.27 $-1.21 Diluted EPS $-1.27 $-1.21 Revenue $ $ 12.48M $ 3.85M Gross Profit $ $ $ Net Income / Loss $ $ -174.44M $ -157.32M Operating Income / Loss $ $ -188.81M $ -171.14M Cost of Revenue $ $ $ Net Cash Flow $ $ 106.25M $ -10.29M PE Ratio